Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2010-01-31
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
NCT01422265
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
NCT06836219
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
NCT06445621
Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
NCT02408536
SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS
NCT06071286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for chemotherapy
* Age \> 18 years
* Signed informed consent
Exclusion Criteria
* Unable or unwilling to participate in interview
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Naples
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandro Pignata, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Francesco Perrone, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Alessandro Morabito, M.D.,
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Ciro Gallo, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Campania Luigi Vanvitelli
Jane Bryce, MSN
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Marzia Falanga, BSN
Role: PRINCIPAL_INVESTIGATOR
S. Giuseppe Moscati Hospital, Avellino
Carmen Pisano, MD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Marilina Piccirillo, MD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Massimo Di Maio, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven-Gynecological Oncology,
Leuven, , Belgium
Charité Universitätsmedizin Berlin Campus Virchow-Klinikum / Frauenklinik
Berlin, , Germany
IRCCS Oncologico Bari, Oncologia Medica
Bari, BA, Italy
Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia
Bergamo, BG, Italy
Ospedale Fatebenefratelli, U.O. di Oncologia
Benevento, BN, Italy
Azienda Ospedaliera G. Rummo
Benevento, BN, Italy
Università Cattolica del Sacro Cuore, Dipartimento di Oncologia
Campobasso, CB, Italy
Azienda Ospedaliera C. Poma
Mantova, MN, Italy
Azienda Ospedaliera V. Cervello
Palermo, PA, Italy
Ospedale S. Massimo, Day Hospital Oncologico
Penne, PE, Italy
Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C
Aviano, PN, Italy
Ospedale S. Chiara
Trento, TN, Italy
Ospedale S. Bortolo ULSS 6, U.O. di Oncologia Medica
Vicenza, VI, Italy
Ospedale Mazzoni
Ascoli Piceno, , Italy
Policlinico Universitario
Bari, , Italy
Universita di Bari Policinico I Clinical Ostetrica e Ginecologica
Bari, , Italy
Ospedale Fatebenefratelli
Benevento, , Italy
Ospedale Senatore Antonio Perrino
Brindisi, , Italy
Universita Cattolica del Sacro Cuore
Campobasso, , Italy
Ospedale A. Manzoni
Lecco, , Italy
Istituto Nazionale Tumori
Milan, , Italy
A.O. Univeristaria Policlinico
Modena, , Italy
Azienda Ospedaliera D. Cotugno
Napoli, , Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Uro-Ginecologico
Napoli, , Italy
Università Federico II, Cattedra di Oncologia Medica
Napoli, , Italy
Ospedale Silvestrini
Perugia, , Italy
Ospedale Civile S. Spirito
Pescara, , Italy
A.O. S. Maria degli Angeli
Pordenone, , Italy
Ospedale S. Giovanni Calibita Fatebenefratelli, UO di Oncologia
Roma, , Italy
A.O. di Udine S. Maria della Misericordia
Udine, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MITO 12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.